;
Ranchi Cancer Hospital and Research Centre (RCHRC), a unit of Tata Cancer Care Foundation, co-hosted the 3rd Annual Conference of the Association of Radiation Oncologists of India – Jharkhand Chapter (AROICON 2025) at Courtyard Marriott, Ranchi, on September 21, 2025. Themed “Break the Ice: Evidence-Based Practice in Oesophageal Cancer, Soft Tissue Sarcoma and Lymphoma,” the conference brought together eminent oncologists from across India to discuss cutting-edge treatment approaches and resource-based cancer management relevant to Jharkhand and similar regions.
The inauguration was led by Prof Dr S. N. Senapati, President AROI, alongside Dr Aftab Alam Ansari (President, AROI Jharkhand Chapter), Dr Deepak Kumar (Secretary, AROI Jharkhand Chapter and Consultant Radiation Oncology, RCHRC), Dr T. M. Singh (Patron) and Dr Amitesh Anand (Senior Surgical Oncologist, RCHRC).
The day featured insightful sessions by eminent experts. Dr Indu Bansal Aggrawal from Paras Hospital, Delhi-Gurugram, spoke on the role of radiation in oesophageal cancer, while Dr Jifmi Jose Manjali of Tata Memorial Hospital, Mumbai, discussed neo-adjuvant radiation and brachytherapy in soft tissue sarcoma. Dr Vivek Verma from Max Hospital, Delhi, highlighted the scope of limb salvage surgery in sarcoma, and Dr Rimpa Basu Achari of Tata Medical Centre, Kolkata, discussed the role of radiation therapy in managing haematological disorders.
Dr Amitesh Anand, Senior Surgical Oncologist, RCHRC, conducted a panel discussion on localised oesophageal squamous cell carcinoma, while RCHRC doctors, Dr Supriya Prasad, Dr Purnima Maggi Dean, and Dr Nikhil Gupta from RCHRC chaired various sessions during the conference.
Discussions also addressed the challenges of cancer management in low-resource settings like Jharkhand, and how oncologists can still deliver best possible outcomes with innovation and teamwork. Speaking on the occasion, Prof Senapati called on the oncology fraternity to work towards establishing centres of excellence in every state to make cancer care more standardised and accessible.
Around 55 doctors including oncologists, gastroenterologists, pathologists, and nuclear medicine specialists from Jharkhand and other regions such as Mumbai, Delhi, Kolkata, and Cuttack attended the conference. By co-hosting AROICON 2025, RCHRC has reinforced its commitment to advancing evidence-based cancer care, fostering multidisciplinary collaboration, and strengthening the oncology ecosystem in Jharkhand through research and knowledge exchange.
We have updated our policy. By continuing to browse this website, you agree to our privacy policy and the use of cookies on the website.